Alvaro Galli

Dr. Alvaro Galli

Institute of Clinical Physiology (IFC) CNR, Pisa, Italy
orcid

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2012 in Human Mutation
Verified
Journal Article
Closed access
PDF file
GMGaël A. Millot
Gaël A. Millot
MCMarcelo Carvalho
Marcelo Carvalho
SCSandrine M Caputo
Sandrine M Caputo
MVMaaike P.G. Vreeswijk
Maaike P.G. Vreeswijk
MBMelissa A. Brown
Melissa A. Brown
OGon behalf of the ENIGMA (Evidence-based Network for the Interpretation of Germline Mutant Alleles) Consortium Functional Assay Working Group
on behalf of the ENIGMA (Evidence-based Network for the Interpretation of Germline Mutant Alleles) Consortium Functional Assay Working Group

6 November 2013 in Human Mutation
Verified
Journal Article
Closed access
PDF file
LGLucia Guidugli
Lucia Guidugli
ACAura Carreira
Aura Carreira
SCSandrine M Caputo
Sandrine M Caputo
AEAsa Ehlen
Asa Ehlen
Alvaro GalliAlvaro Galli
Alvaro Galli
OCon behalf of the ENIGMA consortium
on behalf of the ENIGMA consortium

1 August 2014 in Atherosclerosis
Verified
Journal Article
Closed access
TCTiziana Cervelli
Tiziana Cervelli
DPDaniele Panetta
Daniele Panetta
TNTeresa Navarra
Teresa Navarra
Maria Grazia AndreassiMaria Grazia Andreassi
Maria Grazia Andreassi
Giuseppina BastaGiuseppina Basta
Giuseppina Basta
Serena Del TurcoSerena Del Turco
Serena Del Turco

30 October 2013 in FEMS Yeast Research
Verified
Journal Article
Open access
PDF file
NGNicoletta Guaragnella
Nicoletta Guaragnella
VPVanessa Palermo
Vanessa Palermo
Alvaro GalliAlvaro Galli
Alvaro Galli
LMLoredana Moro
Loredana Moro
Mazzoni CristinaMazzoni Cristina
Mazzoni Cristina
Sergio GiannattasioSergio Giannattasio
Sergio Giannattasio
Use of the yeast Saccharomyces cerevisiae as a model organism to get new insights into p53 and BRCA1/2 function for cancer research and diagnosis.

Verified
Journal Article
Open access
PDF file
TCTiziana Cervelli
Tiziana Cervelli
Andrea BorghiniAndrea Borghini
Andrea Borghini
Alvaro GalliAlvaro Galli
Alvaro Galli
Maria Grazia AndreassiMaria Grazia Andreassi
Maria Grazia Andreassi
Atherosclerosis is the leading cause of morbidity and mortality among Western populations. Over the past two decades, considerable evidence has supported a crucial role for DNA damage in the development and progression of atherosclerosis. These findings support the concept that the prolonged exposure to risk factors (e.g., dyslipidemia, smoking and diabetes mellitus) leading to reactive oxygen species are major stimuli for DNA damage within the plaque. Genomic instability at the cellular level can directly affect vascular function, leading to cell cycle arrest, apoptosis and premature vascular senescence. The purpose of this paper is to review current knowledge on the role of DNA damage and DNA repair systems in atherosclerosis, as well as to discuss the cellular response to DNA damage in order to shed light on possible strategies for prevention and treatment.

1 October 2013 in Atherosclerosis
Verified
Journal Article
Closed access
Andrea BorghiniAndrea Borghini
Andrea Borghini
TCTiziana Cervelli
Tiziana Cervelli
Alvaro GalliAlvaro Galli
Alvaro Galli
Maria Grazia AndreassiMaria Grazia Andreassi
Maria Grazia Andreassi